Angiogenic signaling in Alzheimer's disease

NeuroReport

Volumn 15, Issue 9, 2004, Pages 1507-1510

  Pogue, Aileen I ^a   Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Angiogenesis; DNA array; Gene expression; Inflammation; VEGF

Indexed keywords

MESSENGER RNA;

ALZHEIMER DISEASE; ANGIOGENESIS; ARTICLE; BRAIN; BRAIN BLOOD VESSEL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3142673338     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000130539.39937.1d     Document Type: Article

References (25)

1. Zadeh G and Guha A. Angiogenesis in nervous system disorders. Neurosurgery 2003; 53:1362-1376.
2. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-732.
3. Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finely J, Thompson HW et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci 2003; 44:4163-4170.
4. McGeer EG and McGeer PL. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:741-749.
5. Hoozemans J, Veerhuis R, Rozemuller A and Eikelenboom P. The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications. Drugs Today 2002; 38:429-443.
6. Perlmutter LS and Chui HC. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 1990; 24: 677-686.
7. Lukiw WJ, Carver LA, LeBlanc HJ and Bazan NG. Analysis of 1184 gene transcript levels in Alzheimer's disease CA1 hippocampus: synaptic signaling and transcription factor deficits and up-regulation of proinflammatory pathways. Alzheimer's Reports 2000; 3:61-167.
8. Loring JF, Wen X, Lee JM, Seilhamer J and Somogyi. A gene expression profile of Alzheimer's disease. DNA Cell Biol 2001; 20:683-695.
9. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG and Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 2002; 70: 462-473.
10. Tsuji T, Shiozaki A, Kohno R, Yoshizato K and Shimohama S. Proteomic profiling and neurodegeneration in Alzheimer's disease. Neurochem Res 2002; 27:1245-1253.
11. Lukiw WJ. Gene expression profiling in fetal, aged and Alzheimer hippocampus - a continuum of stress-related signalling. Neurochem Res 2004; 29:1287-1297.
12. Sun GY, Xu J, Jensen MD and Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 2004; 45:205-213.
13. Biancone L, Martino AD, Orlandi V, Conaldi PG, Toniolo A and Camussi G. Development of inflammatory angiogenesis by local stimulation of FAS. J Exp Med 1997; 186:147-152.
14. Lahiri DK, Chen D, Vivien D, Ge YW and Greig NH. Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5′-UTR-binding nuclear factor and its implications in Alzheimer's disease. J Alzheimer's Dis 2003; 5:81-90.
15. Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A et al. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci USA 2003; 100:721-726.
16. Bazan NG, Colangelo V and Lukiw WJ. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Lipid Mediat 2002; 68:197-210.
17. Kaltschmidt B, Linker RA, Deng J and Kaltschrnidt C. Cyclooxygenase-2 is a neuronal target gene of NF-kappaB. BMC Mol Biol 2002; 3:1-12.
18. Kalaria RN, Cohen DL and Premkumar DR. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 1998; 62:101-105.
19. Vagnucci AH and Li WW. Alzheimer's disease and angiogenesis. Lancet 2003; 361:605-608.
20. Hoozemans JJ, Veerhuis R, Janssen I, Rozemuller AJ and Eikelenboom P. Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's disease. Exp Gerontol 2001; 36:559-570.
21. Stiehl DP, Jelkmann W, Wenger RH and Hellwig-Burgel T. Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett 2002; 512:157-162.
22. de la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann HY Acad Sci 2002; 977:196-215.
23. Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood 1997; 89:3315-3332.
24. El Awad B, Kreft B and Wolber EM. Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in proximal tubular cells. Kidney Int 2000; 58:43-50.
25. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 2002; 23:237-243.